Skip to main content

This job has expired

Veterinary Pathologist

Employer
F.Hoffmann-La Roche
Location
Basel, Canton of Basel-Stadt (CH)
Salary
competitive
Closing date
Aug 17, 2022

View more

Discipline
Health Sciences, Pathology
Position Type
Full Time
Job Type
Medical Doctor
Organization Type
All Industry, Biotech

Job Details

The Position

In Roche’s Pharmaceutical Research and Early Development organisation (pRED), we make transformative medicines for patients in order to tackle some of the world’s toughest unmet healthcare needs. At pRED, we are united by our mission to transform science into medicines. Together, we create a culture defined by curiosity, responsibility and humility, where our talented people are empowered and inspired to bring forward extraordinary life-changing innovation at speed. This position is located in Pathology, a Chapter within the PS function, which enables portfolio decisions through proactive and integrative pathology expertise.  We closely collaborate with our therapeutic areas and functions to convert hypotheses into innovative therapeutics.
 

Job mission 

The Veterinary Pathologist will generate scientific insights for our portfolio through portfolio project support and the development and execution of investigative pathology methods and technologies.  
 

Your impact 

  • Collaboratively drive the development, interpretation and reporting of tissue-based assays including: In situ hybridization, immunohistochemistry, immunofluorescence, multiplexing, spatial omics and image analysis

  • Animal and advanced in vitro model characterization through consultation on study design, phenotyping and pathology evaluation of studies 

  • Support drug discovery, research and development through integrative assessment of multiple endpoints and deep mechanistic pathology understanding

  • Direct portfolio project pathology responsibilities

 

Your profile

You are a DVM or Doctor Med. Vet. with the ACVP or ECVP pathology board certification  /eligibility. A PhD and Postdoctoral experience are of a benefit for this role. You have hands on expertise with basic tissue based molecular technologies (e.g. immunohistochemistry, in situ hybridization) including digital analysis approaches. You have expertise in state of the art sequencing and high plex imaging technologies (e.g spatial transcriptomics, single cell sequencing) including the setup of analytical workflows and interpretation of the results. You have profound experience with the generation and phenotyping of transgenic animal models and/or complex 3D in vitro models (e.g organoids, microfluidic systems) including imaging, FACS or omics-based readouts. You have a growth and collaborative mindset with the ability to ask for feedback and continuously develop. You are accountable and have a strong dedication to scientific excellence.

 

Our commitment

Roche commits to recognising talent and aptitude. We prioritize encouraging and supporting our employees in their personal journeys by providing a safe, creative space to help them reflect, make decisions and grow in their career. We are confident that we find the most innovative solutions by gaining different perspectives, asking and answering hard questions, and challenging the status quo. Roche embraces diversity and equal opportunity in a serious yet enthusiastic way; we are devoted to building a team that represents a range of backgrounds, perspectives, and skills. The more inclusive we are, the better our work will be.

 

Who we are

At Roche, more than 100,000 people across 100 countries are pushing back the frontiers of healthcare. Working together, we’ve become one of the world’s leading research-focused healthcare groups. Our success is built on innovation, curiosity and diversity.

Basel is the headquarters of the Roche Group and one of its most important centres of pharmaceutical research. Over 10,700 employees from over 100 countries come together at our Basel/Kaiseraugst site, which is one of Roche`s largest sites. Read more.

Besides extensive development and training opportunities, we offer flexible working options, 18 weeks of maternity leave and 10 weeks of gender independent partnership leave. Our employees also benefit from multiple services on site such as child-care facilities, medical services, restaurants and cafeterias, as well as various employee events.

We believe in the power of diversity and inclusion, and strive to identify and create opportunities that enable all people to bring their unique selves to Roche.

Roche is an Equal Opportunity Employer.

Company

About Roche


Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.

Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management.

Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Moreover, for the tenth consecutive year, Roche has been recognised as the most sustainable company in the Pharmaceuticals Industry by the Dow Jones Sustainability Indices (DJSI).

The Roche Group, headquartered in Basel, Switzerland, is active in over 100 countries and in 2018 employed about 94,000 people worldwide. In 2018, Roche invested CHF 11 billion in R&D and posted sales of CHF 56.8 billion. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan. For more information, please visit www.roche.com.

All trademarks used or mentioned in this release are protected by law.

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert